Futubull Financial APP news, Ningbo Menovo Pharmaceutical (603538.SH) announced that the official website of the Jiangsu Medical Security Bureau recently released the "Fifth batch of national organization pharmaceutical centralized procurement agreement expiration items Jiangsu Alliance continues procurement announcement (5)", the company's wholly-owned subsidiary Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. (referred to as "Menovo Tiankang") bid for Duloxetine hydrochloride enteric-coated capsules and Empagliflozin tablets were awarded.

In this fourth-fifth batch of national organization pharmaceutical centralized procurement, Ningbo Menovo Tiankang's Duloxetine hydrochloride enteric-coated capsules and Empagliflozin tablets completed the continuation of the national organization's centralized procurement, and the selected price ranked in the top 50 from low to high, medical institutions will give priority to using the selected products from this centralized drug procurement.